Monday, July 13, 2020 1:18:40 AM
COVID is Rampant in much of the US and we have a separate CRO coordinating the N America arm of the Multinational trial2b/3. Novotech is working in the Philippines and Dr, Mark has contacts in E Eu... 2b/3 trials have a good momentum, IMO.
Really, this is an OTC stock with a checkered history. Long time shareholders may be rewarded as well as newcomers. Everyone should decide their own Risk to Reward ratio, IMO. Plenty of new DD has been posted, I suggest reading the whole Lancet article for perspective on IPF/CC/COVID and where we might fit in...GLTA...
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM